Lifevantage (NASDAQ:LFVN) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health [Yahoo! Finance]
New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health
Are Investors Undervaluing Lifevantage (LFVN) Right Now? [Yahoo! Finance]
Lifevantage (NASDAQ:LFVN) was upgraded by analysts at Lake Street Capital to a "strong-buy" rating.